Media stories about IMS Health (NYSE:IMS) have trended somewhat positive on Thursday, Accern Sentiment reports. Accern ranks the sentiment of media coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. IMS Health earned a coverage optimism score of 0.19 on Accern’s scale. Accern also gave news articles about the information technology services provider an impact score of 43.0944895609202 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

IMS Health (IMS) traded up $0.99 during trading on Thursday, hitting $31.34. 4,031,300 shares of the stock were exchanged, compared to its average volume of 1,266,943. The company has a debt-to-equity ratio of 2.53, a quick ratio of 1.12 and a current ratio of 1.12. IMS Health has a one year low of $22.36 and a one year high of $31.59. The company has a market cap of $10,330.00 and a P/E ratio of 74.62.

ILLEGAL ACTIVITY WARNING: This news story was originally reported by Daily Political and is the sole property of of Daily Political. If you are reading this news story on another domain, it was stolen and republished in violation of United States and international copyright & trademark laws. The correct version of this news story can be viewed at https://www.dailypolitical.com/2018/01/11/ims-health-ims-earns-media-sentiment-score-of-0-19.html.

About IMS Health

IMS Health Holdings, Inc (IMS) is an information and technology services company that provides solutions to its clients in the healthcare industry. The Company has its presence in over 100 countries. The Company’s data set contains over 10 petabytes of data and over 500 million patient records. It serves healthcare organizations and life science companies, including pharmaceutical, biotechnology, consumer health and medical device manufacturers, as well as distributors, providers, payers, government agencies, policymakers, researchers and the financial community.

Insider Buying and Selling by Quarter for IMS Health (NYSE:IMS)

Receive News & Ratings for IMS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMS Health and related companies with MarketBeat.com's FREE daily email newsletter.